
THE SPECTRUM AND FREQUENCY OF CYSTIC FIBROSIS MUTATIONS IN ALBANIAN PATIENTS Kasmi I, Kasmi G, Basholli B, Sefa HS, Vevecka E *Corresponding Author: Ass. Prof. Irena Kasmi, Pediatric Clinic, Pediatric Department, University
Hospital Center “Mother Teresa”, Tirana, Albania. Address: Street Dibra 372, Tirana, Albania.
Tel: + 355 67 2066175, E-mail: irenakasmi@hotmail.com page: 31
|
REFERENCES
1. Sharma N, et al. Defining the disease liability of vari-
ants in the cystic fibrosis transmembrane conductance
regulator gene. Nat Genet. 2013 Oct;45(10):1160-7.
2. Guo J, Garratt A, Hill A. Worldwide rates of diag-
nosis and effective treatment for cystic fibrosis. J
Cyst Fibros. 2022 May;21(3):456-462. doi: 10.1016/j.
jcf.2022.01.009. Epub 2022 Feb 4. PMID: 35125294
3. Bell SC, DeBoeck K, D AmaralM. New Pharmacolog-
ical Approaches for Cystic Fibrosis: Promises, Prog-
ress, Pitfalls. Pharmacol Ther. 2015 Jan; 145:19-34
4. The molecular genetic epidemiology of cystic fi-
brosis. Human Genetics Program, Chronic Diseases
and Health Promotion, World Health Organization:
Report of a joint meeting of WHO/ECFTN/ICF(M)
A/ECFS; 2002.
5. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet.
2009 May 30; 373(9678):1891-904.
6. www.ecfs.eu/ecfspr
7. Institute of Statistics Albania www.instat.gov.al
8. CFTR2 31 August 2018. www.cftr2.org/mutation list
9. European Cystic fibrosis society. Patient Registry.
At-A-Glance report 2016
10. European Cystic fibrosis society. Patient Registry.
At-A-Glance report 2021
11. Bobadilla JL1, Macek M Jr, Fine JP, Farrell PM. Cys-
tic fibrosis: a worldwide analysis of CFTR mutations-
-correlation with incidence data and application to
screening. Hum Mutat. 2002 Jun; 19(6):575-606.
12. https://www.registroitalianofibrosicistica.it/docu-
menti/servizi/rifc_at_a_glance_2021.pdf
13. Terzic M, Jakimovska M, Fustik S, Jakovska T, Su-
karova-Stefanovska E, Plaseska-Karanfilska D. Cys-
tic fibrosis mutation spectrum in North Macedonia:
A step toward personalized therapy. Balkan Journal
of Medical Genetics. 2019 Aug 28;22(1):35-40.
14. Radivojevic D, Djurisic M, Lalic T, Guc-Scekic M,
Savic J, Minic P. Spectrum of cystic fibrosis mutations
in Serbia and Montenegro and strategy for prenatal
diagnosis. Genet Test. 2004;8(3):276–280. et al.
15. Fustik S, Plaseska Karanfilska D, Terzikj M, Spirevs-
ka L, Stamatova A. Spectrum of CFTR mutations in
Republic of North Macedonia European Respiratory
Journal 2020 56: 2768; DOI: 10.1183/13993003.con-
gress-2020.2768, 16. T. Dörk, M. Macek Jr., F. Mekus, B. Tümm-
ler, J. Tzountzouris, T. Casals, et al. Characterization
of a novel 21-kb deletion, CFTRdele2,3 (21 kb), in
the CFTR gene: a cystic fibrosis mutation of Slavic
origin common in Central and East EuropeHum Ge-
net, 106 (2000), pp. 259-268
17. Ikpa PT, Bijvelds MJ, De Jonge HR. Cystic fibrosis:
toward personalized therapies. Int J Biochem Cell
Biol 2014; 52:192–200
18. Rubin JL1, O’Callaghan L2, Pelligra C3, Konstan
MW4, Ward A3, Ishak JK5, Chandler C3, Liou TG6.
Modeling long-term health outcomes of patients with
cystic fibrosis homozygous for F508del-CFTR treated
with lumacaftor/ivacaftor. TherAdvRespir Dis. 2019
Jan-Dec; 13:175
19. Ponzano S, Nigrelli G, Fregonese L, Eichler I, Ber-
tozzi F, Bandiera T, Galietta LJV3, Papaluca M1. A
European regulatory perspective on cystic fibrosis:
current treatments, trends in drug development and
translational challenges for CFTR modulators. Eur-
Respir Rev. 2018 Apr 13; 27(148).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|